Table 2.
Multivariate analysis of risk factors for PE secondary to SAP.
| Index | B | SE | Wald | P | OR (95% CI) |
|---|---|---|---|---|---|
| Age | −0.028 | 0.021 | 1.779 | 0.182 | 0.973 (0.934∼1.013) |
| BMI | −0.109 | 0.245 | 0.198 | 0.656 | 0.897 (0.554∼1.450) |
| Gender | 0.888 | 0.736 | 1.456 | 0.228 | 2.431 (0.574∼10.284) |
| Fatty liver (n (%)) | −1.512 | 0.863 | 3.074 | 0.080 | 0.220 (0.041∼1.195) |
| Hyperlipidemia (n (%)) | 1.652 | 1.562 | 1.119 | 0.290 | 5.218 (0.244∼111.394) |
| Cholecystitis (n (%)) | −0.167 | 1.018 | 0.027 | 0.870 | 0.846 (0.115∼6.220) |
| Smoking (n (%)) | 0.284 | 0.966 | 0.086 | 0.769 | 1.328 (0.200∼8.813) |
| Alcohol (n (%)) | 0.542 | 1.339 | 0.164 | 0.686 | 1.720 (0.125∼23.740) |
| WBC (×109/L) | 0.036 | 0.076 | 0.226 | 0.634 | 1.037 (0.894∼1.203) |
| NEU | 0.054 | 0.041 | 1.774 | 0.183 | 1.056 (0.975∼1.143) |
| ALB (g/L) | −0.187 | 0.061 | 9.260 | 0.002 | 0.830 (0.736∼0.936) |
| FIB (mg/dl) | 1.520 | 0.477 | 10.154 | 0.001 | 4.573 (1.795∼11.648) |
| GLU (mmol/L) | −0.137 | 0.181 | 0.575 | 0.448 | 0.872 (0.612∼1.243) |
| CRP (mg/L) | 0.045 | 0.018 | 6.114 | 0.013 | 1.046 (1.009∼1.083) |
| AMY (U/L) | −0.008 | 0.019 | 0.187 | 0.666 | 0.992 (0.957∼1.029) |
| LIP (U/L) | 0.394 | 0.150 | 6.931 | 0.008 | 1.484 ( 1.106∼1.990) |
| APACHE-II score | 1.111 | 0.206 | 29.160 | 0.000 | 3.038 (2.030∼4.548) |
| SOFA score | 0.904 | 0.128 | 49.535 | 0.000 | 2.472 (1.920∼3.177) |
| Constant | −23.564 | 9.701 | 5.900 | 0.015 | 0.000 |